Using a population-based analysis to determine the management and treatment of early-stage small-cell lung cancer

Journal of Clinical Oncology

Volumn 34, Issue 10, 2016, Pages 1027-1029

  Pietanza, M Catherine ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; EDITORIAL; HUMAN; OVERALL SURVIVAL; PATIENT SATISFACTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SKULL IRRADIATION; SMALL CELL LUNG CANCER; TREATMENT PLANNING; BRAIN NEOPLASMS; FEMALE; LUNG RESECTION; LUNG TUMOR; MALE; PATHOLOGY; PROCEDURES; SECONDARY; SECONDARY PREVENTION; SMALL CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; CRANIAL IRRADIATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PNEUMONECTOMY; SECONDARY PREVENTION;

EID: 84963641657     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2015.65.6462     Document Type: Editorial

References (26)

1. Aupérin A, Arriagada R, Pignon JP, et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 341: 476-484, 1999.
2. Slotman B, Faivre-Finn C, Kramer G, et al: Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357:664-672, 2007.
3. Sawabata N, Miyaoka E, Asamura H, et al: Japanese lung cancer registry study of 11, 663 surgical cases in 2004: Demographic and prognosis changes over decade. J Thorac Oncol 6:1229-1235, 2011.
4. Vallières E, Shepherd FA, Crowley J, et al: The IASLC Lung Cancer Staging Project: Proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 4:1049-1059, 2009.
5. Mountain CF: Clinical biology of small cell carcinoma: Relationship to surgical therapy. Semin Oncol 5:272-279, 1978.
6. de Hoyos A, De Camp MM: Surgery for small cell lung cancer. Thorac Surg Clin 24:399-409, 2014.
7. Kalemkerian GP, Loo BW, Akerley W, et al: NCCN Guidelines Version 1.2016 Small Cell Lung Cancer: Version 1.2016. Fort Washington, PA, National Comprehensive Cancer Network, 2015.
8. Rudin CM, Ismaila N, Hann CL, et al: Treatment of small-cell lung cancer: American Society of Clinical Oncology endorsement of the American College of Chest Physicians guideline. J Clin Oncol 33:4106-4111, 2015.
9. Yang C-FJ, Chan DY, Speicher PJ, et al: Role of adjuvant therapy in a population-based cohort of patients with early-stage small-cell lung cancer. J Clin Oncol 34:1057-1064.
10. Yu JB, Decker RH, Detterbeck FC, et al: Surveillance Epidemiology and End Results evaluation of the role of surgery for stage I small cell lung cancer. J Thorac Oncol 5:215-219, 2010.
11. Schreiber D, Rineer J, Weedon J, et al: Survival outcomes with the use of surgery in limited-stage small cell lung cancer: Should its role be re-evaluated? Cancer 116:1350-1357, 2010.
12. Varlotto JM, Recht A, Flickinger JC, et al: Lobectomy leads to optimal survival in early-stage small cell lung cancer: A retrospective analysis. J Thorac Cardiovasc Surg 142:538-546, 2011.
13. Karrer K, Ulsperger E: Surgery for cure followed by chemotherapy in small cell carcinoma of the lung. Acta Oncol 34:899-906, 1995.
14. Macchiarini P, Hardin M, Basolo F, et al: Surgery plus adjuvant chemotherapy for T1-3N0M0 small-cell lung cancer: Rationale for current approach. Am J Clin Oncol 14:218-224, 1991.
15. Rea F, Rizzardi G, Zuin A, et al: Outcome and surgical strategy in bronchial carcinoid tumors: Single institution experience with 252 patients. Eur J Cardiothorac Surg 31:186-191, 2007.
16. Tsuchiya R, Suzuki K, Ichinose Y, et al: Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: The Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg 129:977-983, 2005.
17. Combs SE, Hancock JG, Boffa DJ, et al: Bolstering the case for lobectomy in stages I, II, and IIIA small-cell lung cancer using the National Cancer Data Base. J Thorac Oncol 10:316-323, 2015.
18. Sundstrøm S, Bremnes RM, Kaasa S, et al: Cisplatin and etoposide regimen is superior to cyclophosphamide, epirubicin, and vincristine regimen in small-cell lung cancer: Results from a randomized phase III trial with 5 years' follow-up. J Clin Oncol 20:4665-4672, 2002.
19. Brock MV, Hooker CM, Syphard JE, et al: Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come. J Thorac Cardiovasc Surg 129:64-72, 2005.
20. Pignon JP, Tribodet H, Scagliotti GV, et al: Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group. J Clin Oncol 26: 3552-3559, 2008.
21. Pisters KM, Evans WK, Azzoli CG, et al: Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non-small-cell lung cancer guideline. J Clin Oncol 25: 5506-5518, 2007.
22. Rossi A, Di Maio M, Chiodini P, et al: Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: The COCIS meta analysis of individual patient data. J Clin Oncol 30:1692-1698, 2012.
23. Turrisi AT III, Kim K, Blum R, et al: Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265-271, 1999.
24. Inoue M, Miyoshi S, Yasumitsu T, et al: Surgical results for small cell lung cancer based on the new TNM staging system: Thoracic Surgery Study Group of Osaka University, Osaka, Japan. Ann Thorac Surg 70:1615-1619, 2000.
25. Gong L, Wang QI, Zhao L, et al: Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: Is prophylactic cranial irradiation necessary for stage I-III disease? Int J Radiat Oncol Biol Phys 85:196-200, 2013.
26. Douillard JY, Rosell R, De Lena M, et al: Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA nonsmall- cell lung cancer treated with adjuvant chemotherapy: The adjuvant Navelbine International Trialist Association (ANITA) randomized trial. Int J Radiat Oncol Biol Phys 72:695-701, 2008.